Phase 3 study comparing the use of docet
✍
Edgardo Rivera; Jaime A. Mejia; Banu K. Arun; Rosnie B. Adinin; Ronald S. Walter
📂
Article
📅
2008
🏛
John Wiley and Sons
🌐
English
⚖ 120 KB
👁 1 views
## Abstract ## BACKGROUND Previous studies have evaluated 3‐week and weekly docetaxel schedules in patients with metastatic breast cancer (MBC). The varying efficacy results and toxicity profiles noted in these earlier studies led to a comparison of the schedules to determine which was safer and m